232.90
-1.70
(-0.72%)
As of 4:02:01 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 26 | 24 |
| Avg. Estimate | 5.88B | 6.57B | 26.86B | 29.4B |
| Low Estimate | 5.79B | 6.4B | 26.7B | 28.19B |
| High Estimate | 5.99B | 6.71B | 27.01B | 30.99B |
| Year Ago Sales | 5.03B | 5.59B | 23.67B | 26.86B |
| Sales Growth (year/est) | 16.79% | 17.47% | 13.47% | 9.47% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QAA.F | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 4/9/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/8/2025 |
| Initiated | Piper Sandler: Overweight | 4/8/2025 |
| Downgrade | B. Riley Securities: Buy to Neutral | 3/19/2025 |
| Upgrade | BMO Capital: Market Perform to Outperform | 2/25/2025 |
| Maintains | Stifel: Buy to Buy | 2/24/2025 |